title: Effects of different bile salts on steady-state mRNA levels and transcriptional activity of cholesterol 7 alpha-hydroxylase.
abstract: Cholesterol 7 alpha-hydroxylase, the rate-limiting enzyme in the bile acid synthesis pathway, is down-regulated by taurocholate by way of negative feedback control at the level of gene transcription. The molecular basis of regulation of cholesterol 7 alpha-hydroxylase by other hydrophobic bile salts and under more physiological conditions is not known. The aim of this study was to investigate the molecular basis of regulation of cholesterol 7 alpha-hydroxylase by several naturally occurring bile salts in rats with intact enterohepatic circulation. Male Sprague-Dawley rats were pair-fed for 14 days normal chow (control), cholestyramine (5% of diet), cholic acid (1%), chenodeoxycholic acid (1%) or deoxycholic acid (0.25%). When rats were killed, livers were harvested and HMG-CoA reductase specific activity and cholesterol 7 alpha-hydroxylase specific activities, steady-state mRNA levels and transcriptional activity were determined and compared with those of control rats fed normal chow. Compared with results in paired controls, cholestyramine feeding led to an approximate threefold increase in HMG-CoA reductase specific activity. Feeding of hydrophobic bile salts profoundly decreased the specific activity of HMG-CoA reductase. Cholestyramine led to a three-fold increase in cholesterol 7 alpha-hydroxylase specific activity, steady-state mRNA levels and gene transcriptional activity. The feeding of cholic (1%), chenodeoxycholic (1%) and deoxycholic acid (0.25%) led to significant decreases in cholesterol 7 alpha-hydroxylase specific activities (62%, 84% and 97%, respectively), steady-state mRNA levels (72%, 29% and 61%, respectively) and transcriptional activities (44%, 43% and 54%, respectively).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Section of Gastroenterology, McGuire Veterans Administration Medical Center, Richmond, Virginia.
authors.forename: W M
authors.initials: WM
authors.lastname: Pandak
authors.forename: Z R
authors.initials: ZR
authors.lastname: Vlahcevic
authors.forename: D M
authors.initials: DM
authors.lastname: Heuman
authors.forename: K S
authors.initials: KS
authors.lastname: Redford
authors.forename: J Y
authors.initials: JY
authors.lastname: Chiang
authors.forename: P B
authors.initials: PB
authors.lastname: Hylemon
mesh_terms: D000821:Animal Feed; D000818:Animals; D001647:Bile Acids and Salts / Q000008:administration & dosage / Q000502:physiology*; D015152:Blotting, Northern; D015153:Blotting, Western; D002790:Cholesterol 7-alpha-Hydroxylase / Q000235:genetics / Q000378:metabolism*; D002792:Cholestyramine Resin / Q000494:pharmacology; D015536:Down-Regulation; D006903:Hydroxymethylglutaryl CoA Reductases / Q000378:metabolism; D008297:Male; D012333:RNA, Messenger / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014158:Transcription, Genetic
chemical_list: D001647:Bile Acids and Salts; D012333:RNA, Messenger; D002792:Cholestyramine Resin; D006903:Hydroxymethylglutaryl CoA Reductases; D002790:Cholesterol 7-alpha-Hydroxylase